UMLYM23012 // 22-702 // Casulo
Basic Study Information
Purpose:
The purpose of this study is to determine how effective and safe the combination of
rituximab and epcoritamab is in treating patients with Follicular Lymphoma (FL) and
who have not received other treatments for their lymphoma.
The names of the study drugs involved in this study are:
* Rituximab (a type of monoclonal antibody therapy)
* Epcoritamab (a T-cell bispecific antibody)
Location: University of Rochester Medical Center
Lead Researcher (Principal Investigator)
Lead Researcher:
Danielle Wallace
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search